This inventor holds 1 USPTO granted patent. Top assignee: Vufb A.s. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: The Innovations of Josef Urbanec
Introduction
Josef Urbanec is a notable inventor based in Hradec Kralove, Czech Republic. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor compounds. His work has led to the creation of innovative derivatives that hold promise for the treatment of malignant neoplasias.
Latest Patents
Urbanec holds a patent for a novel class of compounds, specifically 6-[X-(2-hydroxyethyl)aminoalkyl]-5,11-dioxo-5,6-dihydro-11H-indeno[-1,2-c]isochinoline derivatives. This patent describes a general formula in which X represents the number of carbon atoms from 0 to 5 in the aminoalkyl group situated on the nitrogen atom in position 6 of the indenoisochinoline structure. The compounds and their derivatives are particularly useful in the preparation of drugs aimed at treating cancer.
Career Highlights
Urbanec is associated with Vufb A.s., where he has been instrumental in advancing research in pharmaceutical applications. His innovative approach to synthesizing antitumor compounds has garnered attention in the scientific community. He has successfully developed methods for preparing these compounds using various chemical processes, including reactions with N-(hydroxyethyl)alkylen diamine and 2-aminoethanol in suitable solvents.
Collaborations
Urbanec has collaborated with notable colleagues, including Milan Melka and Milan Miko. Their combined expertise has contributed to the successful development of new compounds and their applications in medicine.
Conclusion
Josef Urbanec's contributions to the field of medicinal chemistry are significant, particularly in the development of antitumor agents. His innovative work continues to pave the way for advancements in cancer treatment.